Ad
related to: gilead sciences- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- Top Clean Energy Stocks
How to profit from surging demand.
Free report reveals 5 hot stocks.
- Anti-Gold Investor Guide
Investments to buy instead of gold
Free guide to protect your wealth
- Chipmaker Set to Soar Now
Search results
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 4 days agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
1st-Quarter Earnings Season Results, Expectations for 2024
GuruFocus.com via Yahoo Finance· 2 days agoAt the same time, weaker expectations for the noted sectors are primarily driven by the negative...
Should You Invest in the iShares Biotechnology ETF (IBB)?
Zacks· 2 days agoFree Report) , a passively managed exchange traded fund launched on 02/05/2001. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional ...
Should You Invest in the iShares Biotechnology ETF (IBB)?
Zacks via Yahoo Finance· 2 days agoThis ETF has heaviest allocation in the Healthcare sector--about 99.90% of the portfolio. Looking at...
STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CML
MedPage Today· 19 hours agoThe STAMP inhibitor asciminib (Scemblix) had a statistically superior response rate compared with...
Genomic sequencing company expands manufacturing facility - Silicon Valley Business Journal
The Business Journals· 3 days agoThe facility represents the company’s inaugural U.S. supply chain, translating into faster delivery...
Roche’s Sabry retires; Duchenne drug fails confirmatory test
BioPharma Dive via Yahoo Finance· 4 days agoThe veteran executive will be replaced by Boris Zaïtra. Elsewhere, Nippon Shinyaku shared negative...
Longtime Genentech, Roche dealmaker James Sabry to retire - San Francisco Business Times
The Business Journals· 3 days agoJames Sabry, a biotech entrepreneur who 14 years ago started cutting deals for Genentech Inc. and...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 4 days agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
Daily Digest: Musk's xAI scores war chest of funding; OpenAI creates oversight team - San Francisco...
The Business Journals· 3 days agoIn other news, scores of firefighters contained a large blaze that erupted over the weekend at a...
